No profile data available.
Journey Medical Corporation (DERM) is a healthcare company in the skin treatment pharmaceuticals industry, based in Scottsdale, United States, with about 58 full-time employees.
It reported revenue of $61.86 million for fiscal year 2025, up 10.2% from fiscal year 2024, and net income of -$11.43 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $18.51 million, up 23.3% from a year before. Its market capitalization was $178.10 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Journey Medical reported $61.86 million in revenue for fiscal year 2025, up 10.2% from $56.13 million in fiscal year 2024. In Q2 2026 revenue was $18.51 million.
$178.10 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Abeona Therapeutics Inc. (ABEO), Q32 Bio Inc. (QTTB), Sol-Gel Technologies Ltd. (SLGL), Fortress Biotech, Inc. (FBIO).